Drugs / Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05433272 | Aug → Sep 2023 | COVID-19 | Sinovac Biotech (Colombia) S.A.S. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05433272 ↗ |
| Modality | Vaccine | “Trivalent COVID-19 Vaccine (Vero Cell), Inactivated” NCT05433272 ↗ |
| Route | Intramuscular | “The routine of administration is Intramuscular injection into deltoid region.” NCT05433272 ↗ |